Introduction
Phenolic acids coupled with amino acids or amines can be obtained from natural sources or synthetically. It is assumed that these bioactive substances are involved in suppression of deleterious effects of oxidative stress and have a wide range of biological activities such as antioxidant, [1] [2] [3] [4] [5] anticancer 6 and antimicrobial. [7] [8] [9] [10] [11] [12] In fact, the accumulation of hydroxycinnamic acid amides constitutes part of the defence system of plants that is activated as response to various environmental stimuli such as wounding, fungal infection or heavy metal ions. [13] [14] [15] [16] Lee et al. prepared a series of cinnamic acid derivatives and evaluated their biological activities in lipoprotein metabolism. 17 The methyl esters of N-(4-hydroxycinnamoyl)-L-phenylalanine and the dibenzyl ester of N-caffeoyl-aspartic acid showed potent anti-atherogenic and antioxidant activities. Moreover, amides of cinnamic, ferulic and sinapic acids with natural and unnatural Cprotected amino acids have been synthesized and also showed antimicrobial activity, radical scavenging activity against the free 2,2-diphenyl-1-picrylhydrazyl radical and antioxidant activity in bulk oil. [18] [19] Several studies suggest that a cocktail of antioxidants, endowed with different molecular structures and mechanisms of action, result more effective than a single antioxidant, due to the synergic effect between different types of molecules. [20] [21] [22] [23] [24] [25] [26] To highlight possible synergic mechanisms and to better understand mechanistic aspects, the design of modified and/or dualistic molecules is a valuable approach. Studies have confirmed that conjugation between different types of compounds such as amino acids with phenolic acids is useful, not only to investigate structure-activity relationships, but can also constitute a strategy to improve antioxidant efficiency and bioactivity. [27] [28] [29] Another application of phenolic or catecholic amino acids is in the design of new peptide hydrogels that mimic mussel adhesive proteins. 30 The extraordinary ability of mussel adhesive proteins is mainly attributed to the reversible metal-catechol coordination between metals like Fe 3+ and catechol groups from the amino acid 3,4-dihydroxyphenyl-L-alanine (DOPA), and also to other interactions such as cation- interactions. 31 Recently, a new type of injectable hydrogel based on self-assembly of an ABA tri-block copolymer with rapid self-healing properties through mussel-inspired catechol-mediated hydrogen bonding interactions and aromatic interactions and with antibiofouling capability was described. 32 
A R T I C L E I N F O A B S T R A C T
Non-coded amino acids can have a variety of applications such as in structure-activity relationship studies, as antiviral, antitumor, anti-inflammatory or immunosuppressor compounds or in the development of new biomaterials. [33] [34] [35] In particular, dehydroamino acids constitute an important class of non-proteinogenic amino acids with various biological activities including antioxidant. [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] In general, the presence of one or more α,β-dehydroamino acid in a polypeptide chain has strong impact, not only on the secondary structure adopted, but also on their biological behaviour, including antibacterial, antifungal and antitumor activities [36] [37] [38] and resistance to proteolysis. Recently, several low molecular weight dehydrodipeptide hydrogelators were prepared and studied as new drug delivery systems. 49, 50 Thus, the combination of phenolic or catecholic moieties with dehydroamino acids can be a valuable approach to the development of new biologically active compounds.
In our laboratories we developed an efficient method for the synthesis of N,N-diacyl-α,β-dehydroamino acid derivatives by using two equivalents of tertbutyldicarbonate (Boc2O) and 4-dimethylaminopyridine (DMAP) as catalyst in dry acetonitrile. 51 In order to allow the synthesis of N-monoprotected dehydroamino acid derivatives, a modification of this method was subsequently reported. 52 Thus, by reacting β-hydroxyamino acid derivatives with one equivalent of Boc2O and DMAP it was possible to obtain the corresponding β-carbonates that undergo β-elimination by treatment with N,N,N',N'-tetramethylguanidine (TMG).
In this work and in order to explore the effect of combining a dehydroamino acid moiety with phenolic or catecholic acids, an innovative strategy for the synthesis of these conjugates was developed. This new methodology involves the simultaneous tert-butyloxycarbonylation of all hydroxyl groups present in the N-protected -hydroxyamino acids followed by a selective -elimination reaction and cleavage of the aromatic O-tert-butyloxycarbonyl groups. The non-coded amino acids prepared can have biological activity or can be use in the design of new peptide hydrogels that mimic mussel adhesive proteins.
Results and Discussion
The methyl ester of N-(4-hydroxybenzoyl) dehydroalanine was prepared from 4-hydroxybenzoic acid (a) and the methyl ester of serine (1) . The coupling between a and 1 was carried out using 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) and 1-hydroxybenzotriazole (HOBt) to give the methyl ester of N-(4-hydroxybenzoyl)serine in 71% yield (Scheme 1, compound 1a). This compound was treated with two equivalents of Boc2O and DMAP as catalyst in acetonitrile to afford compound 2a (Scheme 1). In the proton NMR spectrum of this compound it is possible to observe two singlets at 1.47 ppm and 1.57 ppm that correspond to the protons of the two tert-butyloxycarbonyl (Boc) groups. Compound 2a was reacted with a solution of TMG in acetonitrile to give the dehydroalanine derivative 3a in 31% yield (Scheme 1). The proton NMR spectrum of 3a shows two singlets at 6.01 ppm and 6.79 ppm caracteristic of the β-CH2 protons of dehydroalanine. Cleavage of the aromatic OBoc group from 3a was accomplished using trifluoroacetic acid, giving compound 4a in 47% yield (Scheme 1).
Scheme 1. Synthesis of the methyl ester of N-(4-hydroxybenzoyl)
dehydroalanine.
In order to improve the low overall yield, a one-pot procedure was tested. Thus, compound 1a was used in a sequential reaction with Boc2O/DMAP, followed by TMG and finally TFA. Compound 4a was isolated in 47% yield (Scheme 2, Table 1 ).
The same methodology was applied with the methyl ester of serine and other phenolic and catecholic acids to give the dehydroalanine derivatives 4c, 4e and 4f (Scheme 2, Table 1 ). Although attempted, it was impossible to isolate the coupling products between serine and protocatechuic acid (b), 2-(3,4-dihydroxyphenyl) acetic acid (d), hydrocaffeic acid (g) and gallic acid (h). This may be due to the high hydrophilic character of compounds 1b, 1d, 1g and 1h when compared with the other serine derivatives (compounds 1a, 1c, 1e and 1f). Scheme 2. One-pot procedure used in the synthesis of the methyl esters of N-phenoyl and N-catechoyl dehydroalanine.
Table 1
Yields obtained in the synthesis of the methyl esters of N-phenoyl and N-catechoyl serine and in the synthesis of the corresponding dehydroalanine derivatives using a one-pot procedure.
Phenolic or catecholic serine derivative

Yield (%)
Phenolic or catecholic dehydroalanine derivative
The same approach was applied to the synthesis of dehydrophenylalanine derivatives N-capped with phenolic or catecholic acids. Thus, the methyl ester of Ncaffeoylphenylserine was prepared by coupling caffeic acid (f) with the methyl ester of phenylserine (5) to give compound 5f (Scheme 3). Compound 5f was treated with three equivalents of Boc2O and DMAP to give compound 6f. The three singlets corresponding to the 27 protons of the three Boc groups were observed in the proton NMR spectrum at 1.47, 1.56 and 1.57 ppm. Compound 6f was reacted with TMG to give dehydrophenylalanine 7f which gave 8f after cleavage of the aromatic O-Boc groups. The dehydrophenylalanine derivative was obtained in 29% overall yield (Scheme 3). As observed for the dehydroalanine derivatives the overall yield in compound 5f was considerably improved using the one-pot procedure (Scheme 4, Table 2 ). Thus, all other phenolic and catecholic acids (a-e, g, h) were reacted with the methyl ester of phenylserine. The lower hidrophylicity of the phenylserine derivatives obtained, allowed the preparation of all N-protected phenylserine derivatives in good yields (Scheme 4, Table 2 , compounds 5a-e, 5g, 5h). The one-pot procedure was carried out with all N-protected phenylserine derivatives to give the Z-isomer of the corresponding dehydrophenylalanine derivative (Scheme 4, Table 2 , compounds 8a-e, 8g). The stereochemistry of the dehydrophenylalanine moieties was confirmed using NOE difference experiments by irradiating the OMe protons and observing an NOE enhancement on the signal of the -CH proton. The N-galloyl phenylserine derivative (compound 5h) was treated in the same conditions but the only product isolated was Ndeprotected dehydrophenylalanine (H-Z-Phe-OMe). This probably resulted from the higher nucleophilic character of the amide nitrogen of the galloyl derivative, which led to the preferential tert-butyloxycarbonylation of the amide, making the galloyl group susceptible to cleavage by TMG. This was described by Ragnarsson and co-workers for cleavage of acyl groups from N-acyl-NBoc-amines. 54 The subsequent treatment with TFA of the N-tert-butyloxycarbonyl dehydrophenylalanine formed led to the methyl ester of dehydrophenylalanine.
Scheme 4.
One-pot procedure used in the synthesis of the methyl esters of N-phenoyl and N-catechoyl dehydrophenylalanine.
Table 2
Yields obtained in the synthesis of the methyl esters of N-phenoyl and N-catechoyl phenylserine and in the synthesis of the corresponding dehydrophenylalanine derivatives using a one-pot procedure.
Phenolic or catecholic phenylserine derivative
Yield (%)
Phenolic or catecholic dehydrophenylalanine derivative
The preparation of C-deprotected dehydroalanine and dehydrophenylalanine derivatives requires the removal of the methyl esters. However, due to the relative ease with which catechol groups oxidize, are prone to nucleophilic attack and phenolic coupling reactions in basic media, it is not possible to remove the methyl esters from compounds 4a, 4c, 4e, 4f and 8a-g. Alternatively, the C-deprotected N-catechoyl dehydroamino acid derivatives were prepared by a sequential tert-butyloxycarbonylation and dehydration; followed by treatment with base to remove the methyl ester and cleavage of the Boc groups with TFA. Compound 5b was reacted with Boc2O/DMAP followed by TMG to give the O-(tertbutyloxycarbonylated) dehydrophenylalanine derivative 7b (Scheme 5). Treatment of this compound with an aqueous solution of NaOH in dioxane, followed by TFA gave the C-deprotected N-catechoyl dehydrophenylalanine derivative (compound 9b).
Scheme 5. Two-step procedure to prepare C-deprotected Nprotocatechoyl dehydrophenylalanine.
Compounds 5e-g were also used as substrates in the same two-step procedure to give the corresponding Nphenoyl or N-catechoyl dehydrophenylalanine derivatives 9e-g (Scheme 6).
Several alanine derivatives were also prepared by coupling phenolic and catecholic acids with the methyl ester of alanine (scheme 7). Some of these compounds were used as standards in the preliminary biological assays described below and all will be used as standards in future screening tests. In the case of AGS cancer cells, compounds 10e, 10f, 4e and 4f where devoid of significant toxicity (Figure 1 ). The introduction of an aryl group in compounds 8e and 8f, exerted some limited toxicity at the highest concentrations tested. For example, 8e caused loss of viability around 20% at 12.5 μM, with 8f exhibiting the same effect at 25 μM. The higher toxicity for compound 8e and 8f may be attributed to their higher liposolubility. In the case of the A549 cell line, which is characterized as a highly aggressive phenotype with high resistance to chemotherapeutic drugs, 55 the alanine, dehydroalanine and dehydrophenylalanine derivatives were either not toxic or caused only minor changes in viability. Results for the non-cancer cell line MRC-5 show that, in general, molecules displayed no toxicity in the concentration range tested.
Conclusions
A new synthetic strategy based on the tertbutyloxycarbonylation of hydroxyl groups present in serine and phenylserine derivatives N-acylated with phenolic and catecholic acids allowed the preparation of a wide range of N-phenolic and N-catecholic dehydroalanines and dehydrophenylalanines in moderate yields. The yields were considerably improved using this methodology in a one-pot procedure. C-Deprotected dehydroamino derivatives were also prepared in a twostep process: the first step comprising sequential tertbutyloxycarbonylation and dehydration; followed by a sequential methyl ester cleavage with base and removal of the tert-butyloxycarbonyl groups with TFA.
These novel compounds can have important biological activities resulting from the synergic effects of both the catechol and the dehydro moieties. Preliminary assays on the toxicity of representative compounds towards two human cancer cell lines show that the most potent molecules were the dehydrophenylalanine derivatives, which can be attributed to their higher liposolubility. Assays of these compounds on cell viability against a non-cancer cell line showed that the molecules display very low or no toxicity in the concentration range tested (up to 25 μM). Thus, the toxicity of the molecules was higher towards cancer cells than non-cancer cells. These results show the impact of the chemical structure upon potency and tropism towards cancer cells. This information will be useful for further modification of these molecules, aiming to increase their bioactivity. They also indicate that these molecules are excellent candidates for incorporation into peptide-based hydrogels with potential in various bioengineering applications such as drug delivery.
Experimental Section
General methods
Melting points (ºC) were determined in a Gallenkamp apparatus and are uncorrected. 1 H and 13 C NMR spectra were recorded on a Bruker Avance II + at 400 and 100.6 MHz, respectively. 1 H-1 H spin-spin decoupling, DEPT  45º, HMQC and HMBC were used to attribute some signals. Chemical shifts are given in ppm and coupling constants in Hz. HRMS data were recorded by the Laboratory for Structural Elucidation of the Materials Centre of the University of Porto on an LTQ Orbitrap TM XL hybrid mass spectrometer (Thermo Fischer Scientific, Bremen, Germany) controlled by LTQ Tune Plus 2.5.5 and Xcalibur 2.1.0. The reactions were monitored by thin layer chromatography (TLC). Column chromatography was performed on Macherey-Nagel silica gel 230-400 mesh. Petroleum ether refers to the boiling range 40-60 ºC. Solvents were used without purification except for acetonitrile which was dried using standard procedures.
Cell culture.
Human gastric carcinoma cell line AGS and human lung carninoma cell line A549 were from Sigma-Aldrich, St. Louis, MO, USA, and human lung fibroblast cell line MRC-5 was from ECACC, Porton Down Salisbury, UK. Cells were cultured as monolayer at 37 °C in a humidified incubator with 5% carbon dioxide. AGS were grown in glutamine-enriched Dulbecco's Modified Eagle Medium (DMEM), supplemented with 1% streptomycin/penicillin and 10% fetal bovine serum (Gibco®), while A549 and MRC-5 cells were grown in DMEM/F-12, supplemented with 1% streptomycin/ penicillin and 10% fetal bovine serum. For subculture, cells were washed with Hank's buffered salt solution (HBSS), treated with 0.25% Trypsin-EDTA solution (Sigma, St. Louis, MO) for 3 min at 37 °C, resuspended in 5 mL of culture medium and centrifuged at 390 g for 4 min. The supernatant was removed and the cell pellet was resuspended in culture medium.
4.1.2.Cell viability.
The MTT assay was conducted as described before. 53 Cells were plated at a density of 1,5x10 4 cells/well for AGS, 1x10 4 cells/well for A549 and 2.5x10 4 cells/well for MRC-5 and allowed to attach for 24 hours. Cells were exposed to the molecules under study in a concentration n range up to 25 μM range, for 24 hours. After this period, the medium was replaced by 100 µL of 0.5 mg/mL MTT solution and incubated for 2 hours. The formazan in each well was then dissolved in 200 µL of a solution of 3:1 DMSO:isopropanol. Finally, the absorbance at 560 nm was read in a Thermo Scientific™ Multiskan™ GO microplate reader.
All determinations were performed in duplicate and the results were confirmed in three independent assays.
Synthesis
Synthesis of the methyl esters of N-phenoyl and Ncatechoyl serine, phenylserine and alanine
General procedure for the synthesis of the methyl esters of N-phenoyl and N-catechoyl serine, phenylserine and alanine
To a solution of the phenolic or catecholic acid in acetonitrile (0.0100 mol dm -3 ), 1.1 equiv. of HOBt was added, followed by 1.1 equiv. of HBTU, 1.1 equiv. of the methyl ester of the amino acid hydrochloride and 2.2 equiv. of NEt3 in an ice bath. After stirring for 4 hours at room temperature, the solvent was evaporated at reduced pressure. The residue was dissolved in ethyl acetate (100 cm 3 ) and washed with KHSO4 (1 mol dm -3 ), NaHCO3 (1 mol dm -3 ) and brine (3 times 25 cm 3 each). The organic layer was dried with MgSO4 and the solvent evaporated at reduced pressure.
Synthesis of 4-hydroxybenzoyl-L-Ser-OMe, (1a)
The general procedure described above was followed with 4-hydroxybenzoic acid (0.345 g, 2.500 mmol) and HCl.H-L-Ser-OMe to give compound 1a (0.425 g, 71.0%) as a colourless oil. 1 
Synthesis of p-coumaroyl-L-Ser-OMe, (1e)
The general procedure described above was followed with pcoumaric acid (0.410 g, 2.500 mmol) and HCl.H-L-SerOMe to give compound 1e (0.374 g, 56.6%) as a light yellow oil. 
Synthesis of caffeoyl-L-Ser-OMe, (1f)
The general procedure described above was followed with caffeic acid (0.450 g, 2.500 mmol) and HCl.H-L-SerOMe to give compound 1f (0.495 g, 70.5%) as a colourless oil. 1 
Synthesis of 4-hydroxybenzoyl-D,L-Phe(-OH)-
OMe, (5a) The general procedure described above was followed with 4-hydroxybenzoic acid (0.345 g, 2.500 mmol) and HCl.H-D,L-Phe(-OH)-OMe to give compound 5a (0.758 g, 96.2%) as a colourless oil. 1 
Synthesis of 2-(4-hydroxyphenyl)acetoyl-D,LPhe(-OH)-OMe, (5c)
The general procedure described above was followed with 2-(4-hydroxyphenyl)acetic acid (0.380 g, 2.500 mmol) and HCl.H-D,L-Phe(-OH)-OMe to give compound 5c (0.735 g, 89.3%) as a light yellow oil. 1 
Synthesis of 2-(3,4-dihydroxyphenyl)acetoyl-D,L-Phe(-OH)-OMe, (5d)
The general procedure described above was followed with 2-(3,4-dihydroxyphenyl)acetic acid (0.420 g, 2.500 mmol) and HCl.H-D,L-Phe(-OH)-OMe to give compound 5d (0.739 g, 85.6%) as a light yellow oil. 
Synthesis of caffeoyl-D,L-Phe(-OH)-OMe, (5f)
The general procedure described above was followed with cafeic acid (0. 
Synthesis of galloyl-D,L-Phe(-OH)-OMe, (5h)
The general procedure described above was followed with gallic acid (0.425 g, 2.500 mmol) and HCl. 
Synthesis of 3,4-dihydroxybenzoyl-L-Ala-OMe, (10b)
The general procedure described above was followed with protocatechuic acid (0.385 g, 2.500 mmol) and HCl.H-L-Ala-OMe to give compound 10b (0.207 g, 34.6%) as a light yellow oil. 
Synthesis of 2-(4-hydroxyphenyl)acetoyl-L-AlaOMe, (10c)
The general procedure described above was followed with 2-(4-hydroxyphenyl)acetic acid (0.380 g, 2.500 mmol) and HCl.H-L-Ala-OMe to give compound 10c (0.415 g, 69.9%) as a light pink solid (from ethyl acetate/petroleum ether). M.p. 97.0-98.0°C. 1 
Synthesis of 2-(3,4-dihydroxyphenyl)acetoyl-LAla-OMe, (10d)
The general procedure described above was followed with 2-(3,4-dihydroxyphenyl)acetic acid (0.420 g, 2.500 mmol) and HCl.H-L-Ala-OMe to give compound 10d (0.327 g, 51.7%) as a light pink oil. 1 
Synthesis of p-coumaroyl-L-Ala-OMe, (10e)
The general procedure described above was followed with p-coumaric acid (0.410 g, 2.500 mmol) and HCl. 
Synthesis of caffeoyl-L-Ala-OMe, (10f)
The general procedure described above was followed with caffeic acid (0. 
Synthesis of hydrocaffeoyl-L-Ala-OMe, (10g)
The general procedure described above was followed with hydrocaffeic acid (0.455 g, 2.500 mmol) and HCl.H-L-Ala-OMe to give compound 10g (0.414 g, 62.0%) as a colourless oil. 1 ), 0.1 equiv. of dimethylaminopyridine was added, followed by 2.5 equiv. of tert-butyldicarbonate for monohydroxylated phenol derivatives or 3.5 equiv. for catechol derivatives, under rapid stirring at room temperature. The reaction was monitored by TLC (ethyl acetate) until all the reactant had been fully tert-butyloxycarbonylated. Then, 4% in volume of N,N,N',N'-tetramethylguanidine was added, stirring was continued and the reaction followed by TLC. When all the tert-butyloxycarbonylated derivative had beeen consumed, the solvent was evaporated at reduced pressure. The residue was redissolved in dichloromethane (0.1 mol dm -3 ) and 25% of TFA was slowly added with vigorous stirring. The reaction was monitored by TLC and when no starting material was detected (≈1 hour) an additional 50 mL of dichloromethane were added. The organic phase was washed with KHSO4 (1 mol dm -3 ), NaHCO3 (1 mol dm -3 ) and brine (3 times 15 cm 3 each). The organic layer was dried with MgSO4 and the solvent evaporated at reduced pressure.
Synthesis of 4-hydroxybenzoyl-Ala-OMe, (4a)
The general procedure described above was followed with 1a (0.239 g, 1.000 mmol) to give compound 4a (0.104 g, 47.1%). 
Synthesis of 2-(4-hydroxyphenyl)acetoyl-Ala-
Synthesis of p-coumaroyl-Ala-OMe, (4e)
The general procedure described above was followed with 1e (0.265 g, 1.000 mmol) to give compound 4e (0. 
Synthesis of caffeoyl-Ala-OMe, (4f)
The general procedure described above was followed with 1f (0.281 g, 1.000 mmol) to give compound 4f (0.068 g, 25.8%) as a light yellow solid. M.p. 174.0-175.0 °C. 
Synthesis of the methyl ester of N-caffeoyl dehydrophenylalanine
Synthesis of caffeoyl-Z-Phe-OMe, (8f)
To a solution of 5f (0.357 g, 1.000 mmol) in dry acetonitrile (0.200 mol dm -3 ), 0.1 equiv. of dimethylaminopyridine was added, followed by 3.5 equiv. of tert-butyldicarbonate. The reaction was monitored by TLC (ethyl acetate) until all the reactant had been fully tert-butyloxycarbonylated. The solvent was evaporated at reduced pressure and the residue was dissolved in ethyl acetate (100 cm ) and 25% of TFA was slowly added with vigorous stirring. The reaction was monitored by TLC and when no starting material was detected (≈1 hour) an additional 50 mL of dichloromethane were added. The organic phase was washed with NaHCO3 (1 mol dm -3 ) and brine (3 times 15 cm 3 each). The organic layer was dried with MgSO4 and the solvent evaporated at reduced pressure to give compound 8f (0.097 g, 60.7%) as an orange oil. 
General one-pot procedure for the synthesis of the methyl esters of N-phenoyl and N-catechoyl dehydrophenylalanine
To a solution of the methyl ester of N-acyl phenylserine in dry acetonitrile (0.200 mol dm -3 ), 0.1 equiv. of dimethylaminopyridine was added, followed by 2.5 equiv. of tert-butyldicarbonate for monohydroxylated fenol derivatives or 3.5 equiv. for catechol derivatives, under rapid stirring at room temperature. The reaction was monitored by TLC (ethyl acetate) until all the reactant had been fully tert-butyloxycarbonylated. Then, 4% in volume of N,N,N',N'-tetramethylguanidine was added, stirring was continued and the reaction followed by TLC. When all the tert-butyloxycarbonylated derivative had been consumed, the solvent was evaporated at reduced pressure. The residue was redissolved in dichloromethane (0.1 mol dm -3 ) and 25% of TFA was slowly added with vigorous stirring. The reaction was monitored by TLC and when no starting material was detected (≈1 hour) an additional 50 mL of dichloromethane were added. The organic phase was washed with KHSO4 (1 mol dm -3 ), NaHCO3 (1 mol dm -3 ) and brine (3 times 15 cm 3 each). The organic layer was dried with MgSO4 and the solvent evaporated at reduced pressure.
Synthesis of 4-hydroxybenzoyl-Z-Phe-OMe, (8a)
The general procedure described above was followed with 5a (0. 
Synthesis of protocatechoyl-Z-Phe-OMe, (8b)
The general procedure described above was followed with 5b (0.331 g, 1.000 mmol) to give compound 8b (0.064 g, 20.5%) as a light orange oil. 
Synthesis of 2-(4-hydroxyphenyl)acetoyl-Z-
Phe-OMe, (8c) The general procedure described above 
Synthesis of 2-(3,4-dihydroxyphenyl)acetoyl-Z-
Phe-OMe, (8d) The general procedure described above was followed with 5d (0.345 g, 1.000 mmol) to give compound 8d (0.142 g, 43.3%) as a light yellow oil. 1 
Synthesis of caffeoyl-Z-Phe-OMe, (8f)
The general procedure described above was followed with 5f (0.357 g, 1.000 mmol) to give compound 8f (0.177 g, 54.5%).
Synthesis of hydrocaffeoyl-Z-Phe-OMe, (8g)
The general procedure described above was followed with 5g (0.359 g, 1.000 mmol) to give compound 8g (0.177 g, 52.0%) as a light yellow oil. 1 
Synthesis of p-coumaroyl-Z-Phe-OH, (9e)
The procedure described above for the synthesis of 7b was followed with 5e (0.341 g, 1.000 mmol) to give compound 7e (0. 
Synthesis of caffeoyl-Z-Phe-OH, (9f)
The procedure described above for the synthesis of 7b was followed with 5f (0.536 g, 1.500 mmol) to give 7f (0.382 g, 47.2%). Compound 7f (0.270 g, 0.500 mmol) was reacted following the procedure described above for the synthesis of 9b to give 9f (0.103 g, 63.2%) as a light green oil. 1 
